Group 1 - Amwell appointed Ricky Goldwasser to its Board of Directors effective June 13, 2024, to enhance its focus on profitability and operational efficiency [1][2] - Goldwasser has a strong financial background with 15 years at Morgan Stanley and experience in leading successful IPOs, including Amwell's [2] - She replaces Deval Patrick, who served on the board since 2015 and contributed significantly to Amwell's telehealth initiatives [3] Group 2 - Amwell is a leading hybrid care delivery platform in the U.S. and globally, connecting providers, payers, patients, and innovators to improve healthcare access and quality [4] - The company supports over 50 health plans, representing more than 100 million covered lives, and aims to transform healthcare through hybrid care delivery [4]
Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors